Listed by the USPTO as FOLEY, SHANON A
Tech Center 1600 • Art Units: 1600 1619 1648 1671
This examiner grants 73% of resolved cases
FOLEY, SHANON A has resolved 991 cases in tech center 1600 and art unit 1600. The allowance rate is 73.3%, and the median time to allowance is 1028 days. The substantial resolved-case record supports a meaningful view of an allowance outcome above half of cases, although the median prosecution period remains significant.
Interviews correspond to an 18.2% lift in allowance outcomes. Boehringer Ingelheim International GmbH, Wisconsin Alumni Research Foundation, and The University of North Carolina at Chapel Hill are the leading companies listed. MYERS BIGEL, P.A., ADE & COMPANY INC., and ARENTFOX SCHIFF LLP are the leading firms shown. Practitioners can use these participants as context when assessing filing and response choices.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18003056 | COMBINATION PORCINE VACCINE | Non-Final OA | BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. |
| 18173535 | BROADLY PROTECTIVE INFLUENZA B VIRUS VACCINES | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18572268 | IN-SITU AND REAL-TIME GENERATION AND ADMINISTRATION OF VIRAL VACCINES USING UV LIGHT INACTIVATION | Non-Final OA | SIGNIFY HOLDING B.V. |
| 18391501 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | Non-Final OA | The Governors of the University of Alberta |
| 17914735 | REVERSE GENETIC SYSTEM FOR SARS-COV-2 | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18557987 | VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS | Final Rejection | PFIZER INC. |
| 18756709 | ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION | Non-Final OA | The Research Foundation for the State University of New York |
| 18559263 | COMPOSITIONS AND METHODS FOR SARS CoV-2 RNA DETECTION | Non-Final OA | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY |
| 18700677 | COMPOSITIONS COMPRISING HIV ENVELOPES TO INDUCE HIV-1 ANTIBODIES | Non-Final OA | Duke University |
| 18780122 | METHODS AND MATERIALS FOR PRODUCING RECOMBINANT VIRUSES IN EUKARYOTIC MICROALGAE | Non-Final OA | The Research Institute at Nationwide Children's Hospital |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy73.3% of resolved applications examined by Shanon A Foley were allowed (991 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +18.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Shanon A Foley took 1,028 days on average from filing to allowance.
Shanon A Foley examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
